← Human Trials & Peer-Reviewed Studies
Intranasal oxytocin may help maintain romantic bonds by decreasing jealousy evoked by either imagined or real partner infidelity
Plain-language guide to PMID 33601928 (2021): double-blind randomized controlled trial study of Oxytocin.
Key Facts
- PMID
- 33601928
- Journal
- Journal of psychopharmacology (Oxford, England)
- Year
- 2021
- Study type
- Randomized Controlled Trial
- Authors
- Zheng X et al. (7 authors)
- DOI
- 10.1177/0269881121991576
What This Study Did, in Plain Language
What Was Tested
Researchers studied Oxytocin in this randomized controlled trial publication.
While romantic jealousy may help to maintain relationships, following partner infidelity and an irretrievable loss of trust it can also promote break-ups.
Who Took Part
By PubMed's age tags, the people studied were teenagers and young adults, both men and women.
Seventy heterosexual couples participated in this double-blind, placebo-controlled, between-subject design study.
Jealousy was firstly quantified in the context of subjects imagining partner infidelity and secondly in a Cyberball game where their partner interacted preferentially with an opposite-sexed rival stranger to simulate partner exclusion, or rejected a neutral stranger but not the partner.
How the Study Was Run
The researchers set it up as a randomized, double-blind and placebo-controlled study.
The participants were allocated by chance, so the Oxytocin group and the comparison group should start out alike.
As a double-blind Oxytocin study, the assignments were hidden from both participants and investigators until the end.
A placebo (an inactive look-alike) gave the Oxytocin group a baseline to be compared against.
What Was Measured
The subject headings attached to it are Arousal, Emotions, Interpersonal Relations, Jealousy, Oxytocin, Sexual Behavior and Sexual Partners.
The authors tagged it with the keywords Cyberball game, Intranasal oxytocin, infidelity, partner bonds and romantic jealousy.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Oxytocin.
The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2021 (Journal of psychopharmacology (Oxford, England)), a journal based in United States.
More context: the Oxytocin compound page, all human trials.
Our Notes on the Compound
Oxytocin: A peptide hormone with established obstetric medical uses and a less settled role in research on behavior, sexual function and appetite.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.